Abstract
The development of catalytic methods for the synthesis of enantiopure saturated heterocycles is a long-standing challenge in asymmetric catalysis. We describe the first highly enantioselective palladium-catalyzed β-C(sp3)−H arylation and olefination of lactams for the preparation of various chiral N-heterocycles bearing quaternary carbon centers. The presence of strongly electron-withdrawing groups on the chiral bifunctional MPAThio ligand is crucial for the reactivity of weakly coordinating lactams. The resulting enantioenriched lactams are readily converted to a family of chiral piperidines and imides that are highly desirable in drug discovery.
Graphical Abstract

Chiral nitrogen-containing heterocycles are ubiquitous in bioactive natural products, pharmaceuticals and materials science.1 Stereoselective construction of chiral lactams and saturated C3-chiral heterocycles is instrumental in the syntheses of various natural products and drug molecules (Scheme 1a).2 Historically, the synthesis of C3-chiral lactams bearing a-quaternary centers has employed enolate alkylation and Michael additions, with the reaction stereoselectivity relying on chiral auxiliary chemistry.3 Catalytic examples are scarce, and transformations are driven predominantly by the process of enolate stabilization.4 In this context, the Stoltz group5 has systematically developed a number of elegant Pd(0)-catalyzed asymmetric enolate alkylation, arylation, and olefination reactions of lactams (Scheme 1b). Typically, these protocols involve the use of strong bases which may not be compatible with certain functional groups.
Scheme 1.

Asymmetric C-H activation of lactams
Since 2008, a wide range of Pd(II)-catalyzed asymmetric C−H activation reactions have been developed through desymmetrization, kinetic resolution, as well as enantioselection of methylene C−H bonds on the same carbon.6 Our group has reported the enantio- and diastereoselective C(sp3)−H arylation of cyclopentane, cyclohexane, and cycloheptane derivatives, along with isopropyl and linear carboxylic acid derivatives. These reactions are facilitated by acidic CONHArF (ArF = p-CF₃C₆F₄) which can coordinate with Pd(II) effectively via imidate form.6b,7 However, neutral amide-directed enantioselective C−H activation remains elusive.8 Especially, lactam-directed C(sp3)-H bonds are challenging as the β-C-H bonds and the directing atom are out-of-plane (Scheme 1b).9 Considering the importance of chiral lactams, we began to develop chiral ligands to enable desymmetrizing C−H activation of lactam substrates containing α-gem-dimethyls. If successful, an array of lactams bearing chiral quaternary carbon centers could be prepared. Here we report a Pd(II)-catalyzed asymmetric C(sp3)−H bond arylation and olefination of 6, 7, 8, and 9-membered lactams (Scheme 1c). A wide range of chiral lactams bearing quaternary centers are obtained with high yields and enantioselectivities using (hetero)aryl iodides and olefins as coupling partners. These chiral lactams can also be reduced to chiral piperidines or oxidized to imides, both of which are widely utilized sp3 rich heterocycles in drug discovery.1a,10
We began our investigation using 1,3,3-trimethylpiperidin-2-one (1a) as the model lactam and methyl 4-iodobenzoate (2a) as the coupling partner to identify suitable chiral ligands and optimize reaction conditions (Table 1). A series of bifunctional chiral ligands previously reported for promoting C(sp3)–H activation, including MPAA (L1),11 mono-N-protected aminomethyl oxazoline (MPAO) (L2),9a mono-benzoyl protected amino thioether ligand (L3),12 and N-acyl sulfonamide ligands (L4)13 failed to provide the desired arylated product, owing to the poor reactivity of the weakly coordinating lactams. In contrast, the chiral mono-protected aminoethyl phenyl thioether (MPAThio) ligand (L5)14 afforded the desired arylation product 3a with high enantioselectivity, albeit with low activity. Initial attempts to improve the yield by adding alkyl substituents to the meta-position of the thiophenol moiety (L6 and L7) were unsuccessful. We hypothesized that the strong coordination between the thioether ligand and the palladium catalyst might be hindering the catalyst’s interaction with the substrate. To address this, we modified the MPAThio ligand by introducing electron-withdrawing groups into the thiophenol. This strategy proved effective, as the ligand bearing a 3,5-diCF3-substituted thiophenol (L8) significantly improved catalyst activity, providing the desired product in 52% yield with >99% ee. Introducing sterics at the backbone of the thioether ligand did not lead to improvements (L9-L12). Finally, extending the reaction time to 56 hours increased the reaction yield to 80% with >99% ee.
Table 1.
|
Conditions: 1a (0.10 mmol), 2a (2.5 equiv.), Pd(OAc)2 (10 mol%), ligand (20 mol%), Ag2O (2.0 equiv.), HFIP (0.50 mL), 50 °C, under air, 36 h.
Yields were determined by 1H NMR analysis of the crude reaction mixture using CH2 Br2 as an internal standard. The ee values were determined by chiral SFC.
t = 56 h.
Isolated yield.
With the optimized conditions established, we investigated the substrate scope by examining a range of substituted aryl and (hetero)aryl iodides (Scheme 2). Aryl iodides bearing electron-withdrawing groups and halide at para-position (2a-g) were smoothly converted to products with good yields and excellent enantioselectivities (93->99% ee). Electron-donating groups were also tolerated, producing the desired arylation products (3h, 3i) in moderate yields (30–43%) and ee (94–97%). Further exploration of meta- (2j-l) and ortho- (2m, 2n) substitutions on aryl iodides yielded chiral products in moderate to good yields (52–71%) with high enantiomeric ratios (97–99% ee). Additionally, substrates containing heterocyclic motifs—such as CF3-substituted pyridines (2o-q), thiophene (2r), and benzofuranyl (2s)—were well tolerated, yielding corresponding products with 97 to >99% ee. Next, we turned our attention to lactams with varying functional groups and ring sizes. Modifying the N-Me group was feasible, resulting in lactams with removable functional groups such as N-Bn (3t) and N-PMB (3u), both exhibiting high enantioselectivity (97% and 98% ee). The kinetic resolution of mono-α-methyl-substituted lactams with different ring sizes (1v-x) were also converted to the desired products with high enantioselectivity (88–91% ee). The 5-methyl δ-lactam (1y), quinolin-2-one (1z), and seven-membered lactam (1aa) were successfully converted to the products with high enantioselectivities (83–92% ee), albeit with more modest yield (28–58%). Moreover, linear native amides (1ab-ad) were also exemplified to show high yield (68–80%) and enantiomeric ratios (95->99% ee). To demonstrate further impact, structurally complex aryl iodides derived from biorelevant molecules and pharmaceuticals were tested to afford 3ae-ah in 59‒79% yields with excellent stereocontrol.
Scheme 2. The substrate scope of enantioselective arylationa,b.

Reaction conditions A: Substrate lactam 1 (0.10 mmol), (hetero)aryl iodide 2 (0.25 mmol), Pd(OAc)2 (10 mol%), L8 (20 mol%), Ag2O (2.0 equiv.), HFIP (0.50 mL), 50 °C, air, 56 hours. a 15 mol% Pd(OAc)2 and 30 mol% L8. b L10 instead of L8.
Further extending this method of enantioselective C−H activation for C(sp3)−H olefination with an olefin coupling partner will open avenues to a wider array of chiral N-heterocycles bearing an alkenyl group.
Consequently, we proceeded to explore the enantioselective reactions of lactams with various mono- or disubstituted olefin coupling partners, an investigation hitherto unreported. Asymmetric olefination of lactam 1a, facilitated by chiral ligand L5, provided the product with 32% yield and 79% ee (Table 2). A comprehensive evaluation of various conditions revealed that utilizing the CF3-substituted MPAThio ligand L12 with 10 mol % of Pd(PhCN)2Cl2, resulted in completion of the reaction in 56 hours at 110 °C, yielding 75% of 5a with 94% ee (Table 2).
Table 2.
|
Conditions: 1a (0.10 mmol), 4a (3.0 equiv.), Pd(PhCN)2Cl2 (10 mol%), ligand (20 mol%), AgNO3 (2.0 equiv.), HFIP (0.50 mL), 110 °C, under air, 56 h.
Yields were determined by 1H NMR analysis of the crude reaction mixture using CH2 Br2 as an internal standard. The ee values were determined by chiral SFC.
Isolated yield.
With the conditions for olefination optimized, the potential range of olefins and lactams was explored, as illustrated in Scheme 3. Commercially mono-substituted olefins, comprising acrylates (4a-f), vinyl sulfonates (4g, h), ethenesulfonyl fluoride15 (ESF, 4i), vinyl phosphonate (4j), and vinyl amide (4k) were smoothly converted into the target products, boasting moderate to high yields and 83–92% ee. It is worth noting that perfluorinated styrene and aliphatic alkenes were also tolerated, leading to the production of fluorinated chiral lactams (5l, m) in low to moderate yields with good enantioselectivities (80–86% ee). Further, we evaluated the potential of 1,1-disubstituted and internal olefins coupling partners. Olefination of the model lactam 1a with dimethyl itaconate (4n), methyl methacrylate (4o) and phenyl methacrylate (4p) were efficient, yielding target products with 41–81% yields and 80–90% ee. Interestingly, the internal olefin maleimide could also be successfully converted to the desired product 5q, albeit in a moderate yield, but with good enantioselectivity (80% ee). Lastly, our study also encompassed the scope of lactams possessing diverse substituents and ring sizes. Similar to arylation reaction, modifying the protecting group of lactam from N-Me to N-PMB and N-Bn was well tolerated, providing chiral lactams (5r-t) in good yields (70–82%) and enantiomeric ratios (87–91% ee). Lactams featuring either a seven-membered ring or a quinolin-2-one were subject to the olefination condition and successfully yielded the desired products (5u, 5v) in moderate to good yields and good enantioselectivities (80–90% ee). Besides, linear native amides were also converted to olefination products (5w, x) in high yields (72–82%) with excellent enantiomeric ratios (83–97% ee). Finally, the acrylic acid ester of L-menthol was smoothly converted to the chiral lactam 5y with moderate yield and good diastereoselectivity.
Scheme 3. The substrate scope of enantioselective olefination.

Reaction conditions B: Substrate lactam 1 (0.10 mmol), acrylate 4 (0.30 mmol), Pd(PhCN)2Cl2 (10 mol%), L12 (20 mol%), AgNO3 (2.0 equiv.), HFIP (0.50 mL), 110 °C, 56 hours. a15 mol% Pd(PhCN)2Cl2 and 30 mol% L12. bL8 instead of L12.
To explore the potential utility of this method, arylation and olefination reactions were performed at 1 mmol scale. The desired arylated and olefinated products were obtained in good yields with excellent enantioselectivities (Scheme 4a). In addition, the gram-scale arylation reaction was successfully conducted, affording 0.9015 g of product 3a in 65% isolated yield. Subsequent synthetic transformations were investigated, as shown in Schemes 4b and 4c. Treatment of the arylation product 3a with CrO3 in acetic acid yielded imide 6a in 52% yield without any loss of enantiomeric purity, along with a side product 6b16 (14% yield). Similarly, treatment 5a with CrO3 produced imide 6c in 60% yield with 88% ee. These imide products, upon deprotection, are important cereblon binding motifs in drug discovery.17 An allylic oxidation reaction of 5a in 1,4-dioxane under reflux conditions afforded 6d in 65% yield and 91% ee. Finally, reduction of the chiral lactams with LiAlH4 generated a variety of chiral piperidines (7a-f) featuring quaternary carbon centers (Scheme 4c). These novel chiral piperidines hold significant potential for future applications in synthetic and medicinal chemistry.
Scheme 4. Scale-up synthesis and synthetic Application.

a Conditions: 3a or 5a (0.10 mmol), CrO3 (3.0 equiv.), AcOH (0.1 M), 80 °C, 24 h. bConditions: 5a (0.10 mmol), SeO2 (2.0 equiv.), 1,4-dioxane (0.1 M), 110 °C, 24 h. cConditions: 3 or 5 (0.10 mmol), LiAlH4 (3.0 equiv.), dry THF (0.1 M), 50 °C, 3 h. d LiAlH4 (6.0 equiv.).
In summary, we have achieved the first palladium-catalyzed asymmetric C(sp3)−H bond activation of lactams. This method demonstrates that the desymmetrization of the dimethyl groups in lactams can be achieved using the electron-deficient chiral MPAThio ligand. Given the ready availability of lactam substrates, (hetero)aryl iodide/olefin coupling partners, and chiral catalyst, this approach offers practical and convenient access to a broad range of enantioenriched chiral lactams. Key features of this method include excellent enantioselectivity, exceptional functional group tolerability, and high step-economy. Notably, the obtained products can be easily transformed into a series of chiral piperidines and imides. We believe this approach will provide a more convenient pathway for the synthesis of drugs and materials containing chiral sp3 rich N-heterocycles.
Supplementary Material
The Supporting Information is available free of charge on the ACS Publications website. Experimental details, full characterization of new compounds including 1H and 13C NMR spectra, HRMS data (PDF)
ACKNOWLEDGMENT
We gratefully acknowledge The Scripps Research Institute, the NIH (NIGMS, R01GM084019) and Bristol Myers Squibb for financial support. We acknowledge Dr. Milan Gembicky, Dr. Jake Bailey, Dr. Erika Samolova, and the UCSD Crystallography Facility for X-ray crystallographic analysis. We thank Dr Jason Lee, Jillian Smith, Brittany Sanchez, and Quynh Nguyen Wong of the TSRI Automated Synthesis Facility for assistance with HRMS and Prep HPLC.
Footnotes
The authors declare no competing financial interest.
REFERENCES
- (1).(a) Vitaku E; Smith DT; Njardarson JT Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem 2014, 57, 10257–10274. [DOI] [PubMed] [Google Scholar]; (b) Kim AN; Ngamnithiporn A; Du E; Stoltz BM Recent Advances in the Total Synthesis of the Tetrahydroisoquinoline Alkaloids (2002−2020). Chem. Rev 2023, 123, 9447–9496. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Escolano C; Amat M; Bosch J Chiral Oxazolopiperidone Lactams: Versatile Intermediates for the Enantioselective Synthesis of Piperidine-Containing Natural Products. Chem. Eur. J 2006, 12, 8198–8207. [DOI] [PubMed] [Google Scholar]; (d) Gunasekar R; Goodyear RL; Silvestri IP Xiao J Recent developments in enantio- and diastereoselective hydrogenation of N-heteroaromatic compounds. Org. Biomol. Chem 2022, 20, 1794–1827. [DOI] [PubMed] [Google Scholar]; (e) Schlack P Polymerizable lactams. Pure App. Chem 1967, 15, 507–524. [Google Scholar]
- (2).(a) Sandmeier T; Carreira EM Synthetic Approaches to Nonaromatic Nitrogen Heterocycles, Chapter 10 Modern Catalytic Enantioselective Approaches to Piperidines, John Wiley & Sons Ltd., Hoboken, NJ, USA, 2020, pp. 249–271. [Google Scholar]; (b) Linghu X; Kennedy-Smith JJ; Toste FD Total synthesis of (+)-fawcettimine. Angew. Chem., Int. Ed 2007, 46, 7671–7673. [DOI] [PubMed] [Google Scholar]; (c) Frolov NA; Vereshchagin AN Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications. Int. J. Mol. Sci 2023, 24, 2937. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Kandepedu N; Abrunhosa-Thomas I; Troin Y Stereoselective strategies for the construction of polysubstituted piperidinic compounds and their applications in natural products’ synthesis. Org. Chem. Front 2017, 4, 1655–1704. [Google Scholar]
- (3).(a) Groaning MD; Meyers AI Chiral Non-racemic bicyclic lactams. Auxiliary-based asymmetric reactions. Tetrahedron 2000, 56, 9843–9873. [Google Scholar]; (b) Amat M; Lozano O; Escolano C; Molins E; Bosch J Enantioselective synthesis of 3,3-disubstituted piperidine derivatives by enolate dialkylation of phenylglycinol-derived oxazolopiperidone lactams. J. Org. Chem 2007, 72, 4431–4439. [DOI] [PubMed] [Google Scholar]; (c) Pandey G; Burugu SK; Singh P; Efficient Strategy for the Construction of Both Enantiomers of the Octahydropyrroloquinolinone Ring System: Total Synthesis of (+)-Aspidospermidine. Org. Lett 2016, 18, 1558–1561. [DOI] [PubMed] [Google Scholar]; Trost B; Brennan M Asymmetric Syntheses of Oxindole and Indole Spirocyclic Alkaloid Natural Products. Synthesis 2009, 2009, 3003–3025. [Google Scholar]
- (4).(a) Hao Y-J; Hu X-S; Zhou Y; Zhou J; Yu J-S Catalytic Enantioselective α-Arylation of Carbonyl Enolates and Related Compounds. ACS Catal. 2019, 10, 955–993. [Google Scholar]; (b) Zhou F; Liu Y-L; Zhou J Catalytic asymmetric synthesis of oxindoles bearing a tetrasubstituted stereocenter at the C-3 position. Adv. Synth. Catal 2010, 352, 1381–1407. [Google Scholar]; (c) Jakubec P; Helliwell M; Dixon DJ Cyclic imine nitro-Mannich/lactamization cascades: a direct stereoselective synthesis of multicyclic piperidinone derivatives. Org. Lett 2008, 10, 4267–4270. [DOI] [PubMed] [Google Scholar]
- (5).(a) Behenna DC; Liu Y; Yurino T; Kim J; White DE; Virgil SC; Stoltz BM Enantioselective construction of quaternary N-heterocycles by palladium-catalysed decarboxylative allylic alkylation of lactams. Nat. Chem 2012, 4, 130–133. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Jette CI; Geibel I; Bachman S; Hayashi M; Sakurai S; Shimizu H; Morgan JB; Stoltz BM Palladium-Catalyzed Construction of Quaternary Stereocenters by Enantioselective Arylation of gamma-Lactams with Aryl Chlorides and Bromides. Angew. Chem., Int. Ed 2019, 58, 4297–4301. [DOI] [PubMed] [Google Scholar]; (c) Moghadam FA; Barbor JP; Chan M; Jette C; Sakurai S; Stoltz BM Formation of All-Carbon Quaternary Centers via Enantioselective Pd-Catalyzed alpha-Vinylation of gamma-Lactams. Org. Lett 2024, 26, 7551–7554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).(a) Giri R; Shi BF; Engle KM; Maugel N; Yu JQ Transition metal-catalyzed C-H activation reactions: diastereoselectivity and enantioselectivity. Chem. Soc. Rev 2009, 38, 3242–3272. [DOI] [PubMed] [Google Scholar]; (b) Saint-Denis TG; Zhu RY; Chen G; Wu QF; Yu JQ Enantioselective C(sp3)‒H bond activation by chiral transition metal catalysts. Science 2018, 359, 6377. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Newton CG; Wang S-G; Oliveira CC; Cramer N Catalytic Enantioselective Transformations Involving C−H Bond Cleavage by Transition-Metal Complexes. Chem. Rev 2017, 117, 8908–8976. [DOI] [PubMed] [Google Scholar]; (d) Liu B; Romine AM; Rubel CZ; Engle KM; Shi B-F Transition-Metal-Catalyzed, Coordination-Assisted Functionalization of Nonactivated C(sp3)–H Bonds. Chem. Rev 2021, 121, 14957–15074. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Antermite D; Bull JA Transition Metal-Catalyzed Directed C(sp3)–H Functionalization of Saturated Heterocycles. Synthesis 2019, 51, 3171–3204. [Google Scholar]
- (7).(a) Chen G; Gong W; Zhuang Z; Andrä MS; Chen Y-Q; Hong X; Yang Y-F; Liu T; Houk KN; Yu J-Q Ligand-accelerated enantioselective methylene C(sp3)-H bond activation. Science 2016, 353, 1023–1027. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Andrä MS; Schifferer L; Pollok CH; Merten C; Gooßen LJ; Yu J-Q Enantio- and Diastereoswitchable C−H Arylation of Methylene Groups in Cycloalkanes. Chem. Eur. J 2019, 25, 8503–8507. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Wu Q-F; Wang X-B; Shen P-X; Yu J-Q Enantioselective C–H Arylation and Vinylation of Cyclobutyl Carboxylic Amides. ACS Catal. 2018, 8, 2577–2581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).(a) Wu QF; Shen PX; He J; Wang XB; Zhang F; Shao Q; Zhu RY; Mapelli C; Qiao JX; Poss MA; Yu J-Q Formation of alpha-chiral centers by asymmetric beta-C(sp3)-H arylation, alkenylation, and alkynylation. Science 2017, 355, 499–503. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Yang Y; Chen J; Shi Y; Liu P; Feng Y; Peng Q; Xu S Catalytic Enantioselective Primary C-H Borylation for Acyclic All-Carbon Quaternary Stereocenters. J. Am. Chem. Soc 2024, 146, 1635–1643. [DOI] [PubMed] [Google Scholar]; (c) Yuan CH; Wang XX; Jiao L Ligand-Enabled Palladium(II)-Catalyzed Enantioselective beta-C(sp3)-H Arylation of Aliphatic Tertiary Amides. Angew. Chem., Int. Ed 2023, 62, e202300854. [DOI] [PubMed] [Google Scholar]
- (9).(a) Park H; Chekshin N; Shen PX; Yu JQ Ligand-Enabled, Palladium-Catalyzed beta-C(sp3)-H Arylation of Weinreb Amides. ACS Catal. 2018, 8, 9292–9297. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Park H; Li Y; Yu JQ Utilizing Carbonyl Coordination of Native Amides for Palladium-Catalyzed C(sp3)-H Olefination. Angew. Chem., Int. Ed 2019, 58, 11424–11428. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Park H; Yu JQ Palladium-Catalyzed [3 + 2] Cycloaddition via Twofold 1,3-C(sp3)-H Activation. J. Am. Chem. Soc 2020, 142, 16552–16556. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Tomanik M; Yu JQ Palladium-Catalyzed Stitching of 1,3-C(sp3)-H Bonds with Dihaloarenes: Short Synthesis of (+/−)-Echinolactone D. J. Am. Chem. Soc 2023, 145, 17919–17925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).Capitosti SM; Hansen TP; Brown ML Facile synthesis of an azido-labeled thalidomide analogue. Org. Lett 2003, 5, 2865–2867. [DOI] [PubMed] [Google Scholar]
- (11).Hu L; Shen PX; Shao Q; Hong K; Qiao JX; Yu JQ Pd(II) -Catalyzed Enantioselective C(sp3)-H Activation/Cross-Coupling Reactions of Free Carboxylic Acids. Angew. Chem., Int. Ed 2019, 58, 2134–2138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (12).Sheng T; Kang G; Zhang T; Meng G; Zhuang Z; Chekshin N; Yu JQ One-Step Synthesis of Chiral 9,10-Dihydrophenanthrenes via Ligand-Enabled Enantioselective Cascade beta,gamma-Diarylation of Acids. Angew. Chem., Int. Ed 2024, e202408603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (13).Strassfeld DA; Chen CY; Park HS; Phan DQ; Yu JQ Hydrogen-bond-acceptor ligands enable distal C(sp3)-H arylation of free alcohols. Nature 2023, 622, 80–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Zhuang Z; Yu JQ Pd(II)-Catalyzed Enantioselective gamma-C(sp3)-H Functionalizations of Free Cyclopropylmethylamines. J. Am. Chem. Soc 2020, 142, 12015–12019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).Chen Q; Mayer P; Mayr H Ethenesulfonyl Fluoride: The Most Perfect Michael Acceptor Ever Found? Angew. Chem., Int. Ed 2016, 55, 12664–12667. [DOI] [PubMed] [Google Scholar]
- (16). The X-ray structure of 6b is provided in the Supporting Information (Table S3), CCDC number is 2384022.
- (17).Millrine D; Kishimoto T A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders. Trends. Mol. Med 2017, 23, 348–361. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
